510(k) device
Levo Gen 2 Tinnitus Therapy System
Levo Medical Corporation · Masker, Tinnitus (KLW, Class II) · First FDA decision Aug 13, 2026, newest Aug 13, 2026Tinnitus
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
593
Naming "Gen 2"
MAUDE reports
943
Brand "Gen 2", since 2015
PubMed studies
124
Mentioning "Gen 2"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K260413 · Decided Aug 13, 2026 · 185 days after receipt
Device type: Masker, Tinnitus (KLW) · Otolaryngology (ENT)
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Gen 2", any status and sponsor, newest update first.
- Reducing Exposure With Air Cleaners and TechnologyPivotal-lookingRecruiting
University of California, BerkeleyAcademic, hospital or other
NCT07914010 · 100 participants (planned) · Start Nov 17, 2026 · Primary completion Sep 2027
Device: Air Cleaner; PM2.5 Monitor with Visual Air Quality Indicator · For: Asthma; COPD (Chronic Obstructive Pulmonary Disease)
Sites: Berkeley, California; San Francisco, California · 3 sites in all
- High-flow Nasal Oxygenation in Obese Patients During Colonoscopy: a Randomized Controlled Trial (COCOON)Pivotal-lookingNot yet recruiting
Assistance Publique - Hôpitaux de ParisAcademic, hospital or other
NCT07947160 · 100 participants (planned) · Start Jan 1, 2027 · Primary completion Jul 1, 2028
Device: Conventional oxygen therapy (oxygen capnography mask); High-flow nasal oxygen therapy (Optiflow®) · For: Obesity (BMI>30)
Sites: Clichy, France; Colombes, France; Paris, France
- AIRE-2 Device for Study of Breath Analysis in IBDActive, not recruiting
McMaster UniversityAcademic, hospital or other
NCT06541938 · 57 participants · Start Aug 28, 2024 · Primary completion Nov 2, 2026
Device: AIRE-2 Portable breath analyzer · For: Inflammatory Bowel Diseases
Sites: Hamilton, Canada
Rabab Mustafa AbdoAcademic, hospital or other
NCT07135739 · 40 participants · Start Sep 1, 2025 · Primary completion Dec 31, 2025
Device: funcional Electrical stimulation combined with mirror therapy · For: Upper Limb Paresis; Spastic Hemiplegia
Sites: Cairo, Egypt
- Clinical Efficacy Evaluation of Supraglottic Airway Device SafeLM™ in Paediatric PopulationRecruiting
National University of MalaysiaAcademic, hospital or other
NCT07266389 · 60 participants (planned) · Start Dec 2, 2025 · Primary completion Nov 30, 2026
Device: SafeLM™ as the airway management device during general anaesthesia · For: Anesthesia; Supraglottic Airway Efficiency; Paediatric Airway Management
Sites: Cheras, Malaysia; Kuala Lumpur, Malaysia
- Duramesh Versus Minimally Invasive IPOM for High-Risk Umbilical Hernia RepairsPivotal-lookingRecruiting
Northwestern UniversityAcademic, hospital or other
NCT07881354 · 160 participants (planned) · Start Oct 23, 2026 · Primary completion Oct 2027
Device: Duramesh; Mesh · For: Umbilical Hernia; Ventral Hernia
Sites: Chicago, Illinois
Tufts Medical CenterAcademic, hospital or other
NCT06242925 · 15 participants · Start Feb 1, 2024 · Primary completion Oct 30, 2026
Device: AbCLO (Abdominal Wall Closure) Device · For: Open Abdomen
Sites: Los Angeles, California; Boston, Massachusetts
Dartmouth-Hitchcock Medical CenterAcademic, hospital or other
NCT07546617 · 36 participants (planned) · Start Nov 30, 2026 · Primary completion Apr 30, 2027
Device: CONVIVO system · For: Endonasal Surgery; Endoscopic Sinus Surgery; Olfactory Dysfunction
Sites: Lebanon, New Hampshire
- Endovascular Brain-Computer Interface for Upper-Limb ParalysisNot yet recruiting
Wei WuAcademic, hospital or other
NCT07934914 · 2 participants (planned) · Start Nov 2, 2026 · Primary completion Jun 2027
Device: Endovascular Venous BCI Type-A Sensor; BCI-Triggered Functional Electrical Stimulation and 1 more · For: Stroke; Hemiplegia; Spinal Cord Injury and 2 more
Sites: Nanjing, China
- Triple Cardiovascular Disease Detection With an Artificial Intelligence-enabled StethoscopePivotal-lookingActive, not recruiting
Imperial College LondonAcademic, hospital or other
NCT05987670 · 200 participants · Start Oct 25, 2023 · Primary completion Jun 23, 2028
Device: AI-stethoscope · For: Heart Failure; Heart Valve Diseases; Atrial Fibrillation and 3 more
Sites: London, United Kingdom
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Gen 2", and for the whole product code for context.
This brand
943 reports: 885 malfunction, 33 injury, 25 death
Whole product code KLW
4 reports: 1 malfunction, 3 injury, 0 death
Newest reports for this brand
- Magnesium Gen.2Malfunction
1823260-2026-04416 · Received Oct 23, 2026 · Event dated Sep 28, 2026
Device type: Photometric Method, Magnesium (JGJ)
Device problem as coded: Non Reproducible Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Tina-quant Albumin Gen.2 - Urine ApplicationMalfunction
1823260-2026-04420 · Received Oct 23, 2026 · Event dated Oct 2, 2026
Device type: Albumin, Antigen, Antiserum, Control (DCF)
Device problem as coded: High Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- PC Gen 2, Non-QSK, Sterile, JapanMalfunction
1220648-2026-13845 · Received Oct 22, 2026 · Event dated Oct 6, 2026
Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
Device problem as coded: Priming Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- Tina-quant Albumin Gen.2Malfunction
1823260-2026-04370 · Received Oct 21, 2026 · Event dated Sep 28, 2026
Device type: Albumin, Antigen, Antiserum, Control (DCF)
Device problem as coded: High Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
1823260-2026-04313 · Received Oct 16, 2026 · Event dated Sep 16, 2026
Device type: Diazo Colorimetry, Bilirubin (CIG)
Device problem as coded: Incorrect Measurement; High Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Gen 2"[tiab]. The summary above synthesizes these.
- Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation.
Andorko JI, Russell RM, Schnepp BC, et al. · Mol Ther · 2025Research Support, Non-U.S. Gov't
- Integration of AI-Generated Images in Clinical Otolaryngology.
Javan R, Cole J, Hsiao S, et al. · Cureus · 2024Editorial
- Concordance of Lipoprotein(a) measurements in mg/dL and nmol/L: Insights from the Lp(a)HORIZON trial.
Cho L, Nordestgaard BG, Chang B, et al. · Atherosclerosis · 2026
- Expanding the human gut microbiome atlas of Africa.
Maghini DG, Oduaran OH, Olubayo LAI, et al. · Nature · 2025Research Support, N.I.H., Extramural
- Expanding the human gut microbiome atlas of Africa.
Maghini DG, Oduaran OH, Wirbel J, et al. · bioRxiv · 2024Preprint
- Gen-2 hand-held optical imager towards cancer imaging: reflectance and transillumination phantom studies.
Gonzalez J, Roman M, Hall M, et al. · Sensors (Basel) · 2012Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Generation and Characterization of Ex Vivo Expanded Tumor-infiltrating Lymphocytes From Renal Cell Carcinoma Tumors for Adoptive Cell Therapy.
Einstein DJ, Halbert B, Denize T, et al. · J Immunother · 2024Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Genetic parameters for egg quality traits in Pekin ducks.
Kroger CA, Lee W, Fraley GS, et al. · Poult Sci · 2024
- Comparison of EEG Signal Spectral Characteristics Obtained with Consumer- and Research-Grade Devices.
Mikhaylov D, Saeed M, Husain Alhosani M, et al. · Sensors (Basel) · 2024Comparative Study
- The multi-mode acoustic gravitational wave experiment: MAGE.
Campbell WM, Goryachev M, Tobar ME · Sci Rep · 2023
- Innovative Orthodontic-Restorative Treatment With Customized CAD/CAM Smartwires.
Weissheimer A, Kravitz ND, Pham J, et al. · J Esthet Restor Dent · 2025Case Reports
- Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.
Fitzgibbon WR, Dang Y, Bunni MA, et al. · Am J Physiol Renal Physiol · 2018Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code KLW.
- Tinnitus Sound Generator ModuleGN Hearing A/S · 510(k) 2020
- Tinnitus Sound Generator ModuleGn Resound A/S · 510(k) 2015
- Multiflex Tinnitus TechnologyStarkey Laboratories, Inc. · 510(k) 2020
- SoundCure Serenade Tinnitus Treatment SystemSoundcure, Inc. · 510(k) 2015
- Tinnitus TherapySivantos GmbH · 510(k) 2026
- Peace N Quiet (0.7.0)Pnq Health · 510(k) 2024
- Tinearity G1 (6103)Duearity AB · 510(k) 2023
- Tinnitogram Signal GeneratorGoldenear Company, Inc. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.